Clinical Trial Update: A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD) [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2b trial evaluating BNC210 tablet formulation in adults with Post-Traumatic Stress Disorder, with the results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• BNC210 Tablet (BNC210)

Snippet

Sponsor: Bionomics Limited | Conditions: Post-Traumatic Stress Disorder | Phase 2 | Status: COMPLETED | Results posted: 2025-02-06